Lv1
40 积分 2024-10-22 加入
Opportunities and limitations of B cell depletion approaches in SLE
2个月前
已完结
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials
6个月前
已完结
Refractory Systemic Lupus Erythematosus: Identification and Pharmacological Management
7个月前
已完结
Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing
8个月前
已完结
嵌合抗原受体T细胞治疗复发难治性自身免疫病专家共识（2025版）
8个月前
已完结
Use of BCMA Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Versus BCMA T-Cell Engagers in BCMA-Exposed Relapsed/Refractory Multiple Myeloma
10个月前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
10个月前
已完结
皖公网安备34019202002308
